The alteration of MNX1-AS1 at 7q36, both via amplification and MYC-induced transcriptional activation, is one of the most common aberrations in several cancers, including non-small cell lung cancer (NSCLC) and CRC [40]. This evidence concerns the gene MNX1 and non-small cell lung carcinoma.